archive-org.com » ORG » S » SCIENCEMAG.ORG

Total: 698

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Maternal Origins of Cancer Transmission | Science Translational Medicine
    currently viewing the summary View Full Text As a service to the community AAAS Science has made this article free with registration Username Enter your Sciencemag org username Password Enter the password that accompanies your username Forgot your username or password Log in Register for Free Join Subscribe Recommend a subscription to your library Help for librarians Science Translational Medicine Vol 1 Issue 7 18 November 2009 Table of Contents Article Tools Email Thank you for your interest in spreading the word about Science Translational Medicine NOTE We only request your email address so that the person you are recommending the page to knows that you wanted them to see it and that it is not junk mail We do not capture any email address Your Email Your Name Send To Enter multiple addresses on separate lines or separate them with commas You are going to email the following Maternal Origins of Cancer Transmission Message Subject Your Name has forwarded a page to you from Science Translational Medicine Message Body Your Name thought you would like to see this page from the Science Translational Medicine web site Your Personal Message Send Message Save to my folders User Name Password Remember my user name password Submit Alerts Please log in to add an alert for this article Username Enter your Sciencemag org username Password Enter the password that accompanies your username Log in Request Permissions Citation tools Maternal Origins of Cancer Transmission By Lily Khidr Science Translational Medicine 18 Nov 2009 7ec26 A leukemia cancer clone transmitted from mother to fetus appears to have bypassed the usual immunological controls Citation Manager Formats BibTeX Bookends EasyBib EndNote tagged EndNote 8 xml Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Share Maternal Origins of Cancer Transmission By Lily Khidr Science Translational Medicine

    Original URL path: http://stm.sciencemag.org/content/1/7/7ec26.summary (2016-02-10)
    Open archived version from archive


  • Maternal Origins of Cancer Transmission | Science Translational Medicine
    full text As a service to the community AAAS Science has made this article free with registration Username Enter your Sciencemag org username Password Enter the password that accompanies your username Forgot your username or password Log in Register for Free Join Subscribe Recommend a subscription to your library Help for librarians Science Translational Medicine Vol 1 Issue 7 18 November 2009 Table of Contents Article Tools Email Thank you for your interest in spreading the word about Science Translational Medicine NOTE We only request your email address so that the person you are recommending the page to knows that you wanted them to see it and that it is not junk mail We do not capture any email address Your Email Your Name Send To Enter multiple addresses on separate lines or separate them with commas You are going to email the following Maternal Origins of Cancer Transmission Message Subject Your Name has forwarded a page to you from Science Translational Medicine Message Body Your Name thought you would like to see this page from the Science Translational Medicine web site Your Personal Message Send Message Save to my folders User Name Password Remember my user name password Submit Alerts Please log in to add an alert for this article Username Enter your Sciencemag org username Password Enter the password that accompanies your username Log in Request Permissions Citation tools Maternal Origins of Cancer Transmission By Lily Khidr Science Translational Medicine 18 Nov 2009 7ec26 A leukemia cancer clone transmitted from mother to fetus appears to have bypassed the usual immunological controls Citation Manager Formats BibTeX Bookends EasyBib EndNote tagged EndNote 8 xml Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Share Maternal Origins of Cancer Transmission By Lily Khidr Science Translational Medicine 18 Nov 2009 7ec26 A

    Original URL path: http://stm.sciencemag.org/content/1/7/7ec26.full (2016-02-10)
    Open archived version from archive

  • Understanding Drug Resistance in Tuberculosis | Science Translational Medicine
    the View Full Text As a service to the community AAAS Science has made this article free with registration Username Enter your Sciencemag org username Password Enter the password that accompanies your username Forgot your username or password Log in Register for Free Join Subscribe Recommend a subscription to your library Help for librarians Science Translational Medicine Vol 1 Issue 7 18 November 2009 Table of Contents Article Tools Email Thank you for your interest in spreading the word about Science Translational Medicine NOTE We only request your email address so that the person you are recommending the page to knows that you wanted them to see it and that it is not junk mail We do not capture any email address Your Email Your Name Send To Enter multiple addresses on separate lines or separate them with commas You are going to email the following Understanding Drug Resistance in Tuberculosis Message Subject Your Name has forwarded a page to you from Science Translational Medicine Message Body Your Name thought you would like to see this page from the Science Translational Medicine web site Your Personal Message Send Message Save to my folders User Name Password Remember my user name password Submit Alerts Please log in to add an alert for this article Username Enter your Sciencemag org username Password Enter the password that accompanies your username Log in Request Permissions Citation tools Understanding Drug Resistance in Tuberculosis By Heather B McDonald Science Translational Medicine 18 Nov 2009 7ec27 Resistance to one second line drug for TB does not necessarily imply resistance to a related drug as previously assumed Citation Manager Formats BibTeX Bookends EasyBib EndNote tagged EndNote 8 xml Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Share Understanding Drug Resistance in Tuberculosis By Heather B McDonald Science

    Original URL path: http://stm.sciencemag.org/content/1/7/7ec27 (2016-02-10)
    Open archived version from archive

  • Understanding Drug Resistance in Tuberculosis | Science Translational Medicine
    summary View Full Text As a service to the community AAAS Science has made this article free with registration Username Enter your Sciencemag org username Password Enter the password that accompanies your username Forgot your username or password Log in Register for Free Join Subscribe Recommend a subscription to your library Help for librarians Science Translational Medicine Vol 1 Issue 7 18 November 2009 Table of Contents Article Tools Email Thank you for your interest in spreading the word about Science Translational Medicine NOTE We only request your email address so that the person you are recommending the page to knows that you wanted them to see it and that it is not junk mail We do not capture any email address Your Email Your Name Send To Enter multiple addresses on separate lines or separate them with commas You are going to email the following Understanding Drug Resistance in Tuberculosis Message Subject Your Name has forwarded a page to you from Science Translational Medicine Message Body Your Name thought you would like to see this page from the Science Translational Medicine web site Your Personal Message Send Message Save to my folders User Name Password Remember my user name password Submit Alerts Please log in to add an alert for this article Username Enter your Sciencemag org username Password Enter the password that accompanies your username Log in Request Permissions Citation tools Understanding Drug Resistance in Tuberculosis By Heather B McDonald Science Translational Medicine 18 Nov 2009 7ec27 Resistance to one second line drug for TB does not necessarily imply resistance to a related drug as previously assumed Citation Manager Formats BibTeX Bookends EasyBib EndNote tagged EndNote 8 xml Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Share Understanding Drug Resistance in Tuberculosis By Heather B McDonald Science

    Original URL path: http://stm.sciencemag.org/content/1/7/7ec27.summary (2016-02-10)
    Open archived version from archive

  • Understanding Drug Resistance in Tuberculosis | Science Translational Medicine
    a service to the community AAAS Science has made this article free with registration Username Enter your Sciencemag org username Password Enter the password that accompanies your username Forgot your username or password Log in Register for Free Join Subscribe Recommend a subscription to your library Help for librarians Science Translational Medicine Vol 1 Issue 7 18 November 2009 Table of Contents Article Tools Email Thank you for your interest in spreading the word about Science Translational Medicine NOTE We only request your email address so that the person you are recommending the page to knows that you wanted them to see it and that it is not junk mail We do not capture any email address Your Email Your Name Send To Enter multiple addresses on separate lines or separate them with commas You are going to email the following Understanding Drug Resistance in Tuberculosis Message Subject Your Name has forwarded a page to you from Science Translational Medicine Message Body Your Name thought you would like to see this page from the Science Translational Medicine web site Your Personal Message Send Message Save to my folders User Name Password Remember my user name password Submit Alerts Please log in to add an alert for this article Username Enter your Sciencemag org username Password Enter the password that accompanies your username Log in Request Permissions Citation tools Understanding Drug Resistance in Tuberculosis By Heather B McDonald Science Translational Medicine 18 Nov 2009 7ec27 Resistance to one second line drug for TB does not necessarily imply resistance to a related drug as previously assumed Citation Manager Formats BibTeX Bookends EasyBib EndNote tagged EndNote 8 xml Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Share Understanding Drug Resistance in Tuberculosis By Heather B McDonald Science Translational Medicine 18 Nov 2009

    Original URL path: http://stm.sciencemag.org/content/1/7/7ec27.full (2016-02-10)
    Open archived version from archive

  • Targeting the JMJD2 Histone Demethylases to Epigenetically Control Herpesvirus Infection and Reactivation from Latency | Science Translational Medicine
    author on this site Ganesha Rai NIH Chemical Genomics Center National Center for Advancing Translational Sciences National Institutes of Health Rockville MD 20850 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ajit Jadhav NIH Chemical Genomics Center National Center for Advancing Translational Sciences National Institutes of Health Rockville MD 20850 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anton Simeonov NIH Chemical Genomics Center National Center for Advancing Translational Sciences National Institutes of Health Rockville MD 20850 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site David J Maloney NIH Chemical Genomics Center National Center for Advancing Translational Sciences National Institutes of Health Rockville MD 20850 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Thomas M Kristie Laboratory of Viral Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda MD 20892 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Article Figures Data Info Metrics eLetters PDF You are currently viewing the pdf html View Full Text As a service to the community AAAS Science has made this article free with registration Username Enter your Sciencemag org username Password Enter the password that accompanies your username Forgot your username or password Log in Register for Free Join Subscribe Recommend a subscription to your library Help for librarians Science Translational Medicine Vol 5 Issue 167 09 January 2013 Table of Contents Article Tools Email Thank you for your interest in spreading the word about Science Translational Medicine NOTE We only request your email address so that the person you are recommending the page to knows that you wanted them to see it and that it is not junk mail We do not capture any email address Your Email Your Name Send To Enter multiple addresses on separate lines or separate them with commas You are going to email the following Targeting the JMJD2 Histone Demethylases to Epigenetically Control Herpesvirus Infection and Reactivation from Latency Message Subject Your Name has forwarded a page to you from Science Translational Medicine Message Body Your Name thought you would like to see this page from the Science Translational Medicine web site Your Personal Message Send Message Download Powerpoint Print Save to my folders User Name Password Remember my user name password Submit Alerts Please log in to add an alert for this article Username Enter your Sciencemag org username Password Enter the password that accompanies your username Log in Request Permissions Citation tools Targeting the JMJD2 Histone Demethylases to Epigenetically Control Herpesvirus Infection and Reactivation from Latency By Yu Liang Jodi L Vogel Jesse H Arbuckle Ganesha Rai Ajit Jadhav Anton Simeonov David J Maloney Thomas M Kristie Science Translational Medicine 09 Jan 2013 167ra5 Inhibitors of cellular

    Original URL path: http://stm.sciencemag.org/content/5/167/167ra5.full.pdf+html? (2016-02-10)
    Open archived version from archive

  • Repurposing the Pap Smear: One Step Closer to Gynecologic Cancer Screening | Science Translational Medicine
    Scholar Find this author on PubMed Search for this author on this site Article Figures Data Info Metrics eLetters PDF You are currently viewing the abstract View Full Text Username Enter your Sciencemag org username Password Enter the password that accompanies your username Forgot your username or password Log in Join Subscribe Purchase Article Activate Member Account Renew Subscription Recommend a subscription to your library Help for librarians Abstract Prevention and early detection remain essential to decreasing cancer mortality Screening DNA in Pap smears has the potential to increase the rate of early detection of endometrial and ovarian cancers In this issue of Science Translational Medicine Kinde and colleagues use advanced sequencing technology to evaluate DNA to screen for gynecologic malignancies Copyright 2013 American Association for the Advancement of Science View Full Text Science Translational Medicine Vol 5 Issue 167 09 January 2013 Table of Contents Article Tools Email Thank you for your interest in spreading the word about Science Translational Medicine NOTE We only request your email address so that the person you are recommending the page to knows that you wanted them to see it and that it is not junk mail We do not capture any email address Your Email Your Name Send To Enter multiple addresses on separate lines or separate them with commas You are going to email the following Repurposing the Pap Smear One Step Closer to Gynecologic Cancer Screening Message Subject Your Name has forwarded a page to you from Science Translational Medicine Message Body Your Name thought you would like to see this page from the Science Translational Medicine web site Your Personal Message Send Message Download Powerpoint Print Save to my folders User Name Password Remember my user name password Submit Alerts Please log in to add an alert for this

    Original URL path: http://stm.sciencemag.org/content/5/167/167ps1 (2016-02-10)
    Open archived version from archive

  • Repurposing the Pap Smear: One Step Closer to Gynecologic Cancer Screening | Science Translational Medicine
    of Medical Oncology Dana Farber Cancer Institute Boston MA 02215 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Article Figures Data Info Metrics eLetters PDF Log in to view full text Username Enter your Sciencemag org username Password Enter the password that accompanies your username Forgot your username or password Log in Join Subscribe Purchase Article Activate Member Account Renew Subscription Recommend a subscription to your library Help for librarians Science Translational Medicine Vol 5 Issue 167 09 January 2013 Table of Contents Article Tools Email Thank you for your interest in spreading the word about Science Translational Medicine NOTE We only request your email address so that the person you are recommending the page to knows that you wanted them to see it and that it is not junk mail We do not capture any email address Your Email Your Name Send To Enter multiple addresses on separate lines or separate them with commas You are going to email the following Repurposing the Pap Smear One Step Closer to Gynecologic Cancer Screening Message Subject Your Name has forwarded a page to you from Science Translational Medicine Message Body Your Name thought you would like to see this page from the Science Translational Medicine web site Your Personal Message Send Message Download Powerpoint Print Save to my folders User Name Password Remember my user name password Submit Alerts Please log in to add an alert for this article Username Enter your Sciencemag org username Password Enter the password that accompanies your username Log in Request Permissions Citation tools Repurposing the Pap Smear One Step Closer to Gynecologic Cancer Screening By Shannon N Westin Gordon B Mills Andrea P Myers Science Translational Medicine 09 Jan 2013 167ps1 DNA testing has

    Original URL path: http://stm.sciencemag.org/content/5/167/167ps1.full (2016-02-10)
    Open archived version from archive



  •